Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Hempfusion Wellness Inc

Healthcare US CBDHF

0.0USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

--
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00163M
  • Volume600
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-23.05734M
  • Revenue TTM6.26M
  • Revenue Per Share TTM0.05
  • Gross Profit TTM 1.69M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - -37.95824M -12.15197M -1.56660M
Minority interest - - - - -
Net income - - -37.95824M -12.15197M -1.56660M
Selling general administrative - - 11.14M 5.75M 1.32M
Selling and marketing expenses - - 7.53M 6.70M 0.57M
Gross profit - 9.02M 0.40M 0.61M 0.49M
Reconciled depreciation - - 0.63M 0.28M 0.00626M
Ebit - 8.78M -19.11027M -13.04290M -1.43614M
Ebitda - 9.02M -18.47575M -12.76478M -1.42989M
Depreciation and amortization 0.23M 0.24M 0.63M 0.28M 0.00626M
Non operating income net other - - - - -
Operating income - 9.02M -19.29128M -12.28677M -1.41546M
Other operating expenses - - 22.97M 15.22M 2.62M
Interest expense - - 0.04M 0.02M 0.13M
Tax provision - - 0.00000M - -
Interest income - - - - -
Net interest income - - -0.11221M -1.04559M -0.13390M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.14M 0.21M 0.11M
Total revenue - 9.02M 3.82M 3.02M 1.21M
Total operating expenses - - 19.54M 12.82M 1.91M
Cost of revenue - - 3.42M 2.40M 0.71M
Total other income expense net - - -18.70443M 1.10M -0.02033M
Discontinued operations - - - - -
Net income from continuing ops - - -37.95824M -12.15197M -1.56660M
Net income applicable to common shares - - -37.95824M -12.15197M -1.56660M
Preferred stock and other adjustments - - - - -
Breakdown 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Total assets 14.36M 38.62M 3.55M 1.56M 0.78M
Intangible assets - 6.60M - - -
Earning assets - - - - -
Other current assets 1.53M 1.78M 1.06M 1.06M 0.36M
Total liab 17.89M 7.72M 0.38M 2.35M 0.45M
Total stockholder equity -3.53670M 30.90M 3.17M -0.79302M 0.33M
Deferred long term liab - - - - -
Other current liab 13.98M 2.51M 0.14M 0.29M 0.08M
Common stock 45.00M 45.00M 1.45M 1.45M 1.45M
Capital stock 45.00M 45.00M 6.74M - -
Retained earnings -53.91800M -15.95976M -3.80779M -2.24119M -1.11861M
Other liab - 1.40M - - -
Good will 0.00000M 1.11M - - -
Other assets - - - - -
Cash 9.26M 26.26M 1.27M 0.11M 0.07M
Cash and equivalents - - - - -
Total current liabilities 17.73M 6.11M 0.38M 2.35M 0.45M
Current deferred revenue 1.37M 1.72M - 0.00714M 0.00520M
Net debt -9.03693M -25.97015M -1.27341M 1.72M 0.17M
Short term debt 0.06M 0.08M - 1.83M 0.25M
Short long term debt - - - 1.83M -
Short long term debt total 0.23M 0.29M - 1.83M 0.25M
Other stockholder equity 5.38M 1.85M 0.25M - -
Property plant equipment 0.53M 0.42M 0.02M 0.02M 0.00753M
Total current assets 13.83M 30.49M 3.53M 1.54M 0.77M
Long term investments - - - - -
Net tangible assets -3.53670M 23.19M -2.11429M -0.79302M 0.33M
Short term investments - - - - -
Net receivables 0.46M 0.67M 0.41M 0.14M 0.04M
Long term debt - - - - -
Inventory 2.58M 1.77M 0.79M 0.24M 0.29M
Accounts payable 2.32M 1.80M 0.24M 0.23M 0.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.53M 8.13M 0.02M 0.02M 0.00753M
Capital lease obligations 0.23M 0.29M - - -
Long term debt total - - - - -
Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Investments - -2.02455M -4.45220M -0.01266M -0.01218M
Change to liabilities - 0.53M 1.43M 0.05M 0.11M
Total cashflows from investing activities - -2.02455M -4.45220M -0.01266M -0.01218M
Net borrowings - -0.08564M -0.18423M 0.18M 1.64M
Total cash from financing activities - -0.11087M 41.15M 3.37M 1.64M
Change to operating activities - 0.25M -0.72268M -0.00021M -0.69612M
Net income - -37.95824M -12.15197M -1.56660M -1.12258M
Change in cash - -16.99598M 24.99M 1.17M 0.03M
Begin period cash flow 9.26M 26.26M 1.27M 0.11M 0.07M
End period cash flow 9.26M 9.26M 26.26M 1.27M 0.11M
Total cash from operating activities - -14.86056M -11.70994M -2.19637M -1.59078M
Issuance of capital stock - 0.00000M 41.33M 3.04M -
Depreciation - 0.63M 0.28M 0.00626M 0.00183M
Other cashflows from investing activities - - - - -
Dividends paid - 0.00000M - - -
Change to inventory - -0.80484M -0.58098M -0.54563M 0.05M
Change to account receivables - 0.14M -0.17963M -0.27158M -0.09506M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.02523M -0.13310M 0.33M 1.64M
Change to netincome - 22.35M 0.23M 0.13M 0.16M
Capital expenditures 0.00000M 0.25M 0.10M 0.01M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 0.11M -0.04918M -0.76648M -0.62783M
Stock based compensation - 3.52M 0.13M - -
Other non cash items - 0.04M 0.00855M 0.13M 0.16M
Free cash flow - -15.11483M -11.81451M -2.20903M -1.60295M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBDHF
Hempfusion Wellness Inc		 - -% - - - 0.0003 0.001 0.0004 0.15
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.64 2.10% 31.05 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Hempfusion Wellness Inc., a health and wellness supplement company, offers CBD and probiotic products in the United States. It provides tinctures, capsules, gummies, and topical creams and gel products. The company offers its products under the HempFusion, Sagely Naturals, and Apothecanna brands in approximately 18,000 retail stores in the United States and internationally. It company sells its products through its e-commerce websites. Hempfusion Wellness Inc. is based in Colorado, Denver.

Hempfusion Wellness Inc

1550 Larimer Street, Denver, CO, United States, 80202

Key Executives

Name Title Year Born
Dr. Jason Mitchell Co-Founder, CEO, Pres & Director 1972
Mr. Ian DeQueiroz Co-Founder, Chief of Brand Strategy & Partnerships and Director 1985
Ms. Maria Leal Chief Financial Officer NA
Mr. Jonathan Visser Chief Operating Officer 1973
Mr. G. Scott Greenburg Corp. Sec., Chief Legal Officer, Gen. Counsel, Managing Partner & Director 1956
Ms. Ola Lessard Chief Marketing Officer 1969
Mr. Daniel Brody Chief Corp. Officer NA
Mr. Daniel Brody Chief Corporate Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions